Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: J Rheumatol. 2015 Nov 15;42(12):2398–2403. doi: 10.3899/jrheum.150545

Knee Pain Patterns and Associations with Pain and Function in Persons With or at Risk for Symptomatic Radiographic Osteoarthritis: A Cross Sectional Analysis

Daniel L Riddle 1, Mateusz Makowski 2
PMCID: PMC4668229  NIHMSID: NIHMS719646  PMID: 26568598

Abstract

Objectives

Knee pain location among persons with knee pain is routinely assessed in clinical practice. We determined associations between pain location using a highly reliable method, extent and location of radiographic knee osteoarthritis and self-reported function and pain with activity.

Methods

The Osteoarthritis Initiative data were used to examine reports of pain location (localized, regional or global) and type and extent of knee OA. Multivariable ANCOVA models were used to determine associations between KOOS Pain and WOMAC Function scales and pain location after adjusting for potential confounding. We also used radar graphs to illustrate pain patterns for various locations and severity of knee OA.

Results

Radar graphs of 2,696 knees indicated that pain pattern and location and extent of knee OA demonstrate substantial overlap. A race by pain location interaction was found for WOMAC Function but not for KOOS Pain scores. Global knee pain is associated (p<0.001) with substantially worse function (by 6.5 points in African Americans) as compared to pain that is localized. Knee pain reported as global is independently associated (p<0.001) with clinically important lower (worse by 3.9 points) KOOS pain scores as compared to pain that is localized.

Conclusions

Pain patterns are not useful for inferring potential location or severity of knee OA in individual patients but knee pain patterns that are global are independently associated with worse pain and function compared to localized pain and associations differ for function based on race.


Patients are routinely asked during a clinical encounter to report the location(s) of their knee pain. Clinicians use this information for a variety of reasons. For example, pain over the area of the pes anserine bursa may suggest bursitis while pain on the medial side of the knee in a middle-aged or elderly person may suggest medial compartment tibiofemoral osteoarthritis (OA). The location of knee pain also may trigger more extensive diagnostic tests. Tibiofemoral joint line pain in some persons, for example, may lead to an MRI to assess for the presence of a meniscus tear.

The diagnostic utility of knee pain location assessment for inferring radiographic OA status has been examined and these studies have suggested that pain location is not strongly associated with tibiofemoral osteoarthritis (13). However, these studies either examined small samples (1) or did not consider the impact of specific Kellgren and Lawrence (K&L) grades or tibiofemoral compartment involved (3).

Patterns of knee pain and associations with pain and function also have been studied (1;3). Persons with generalized knee pain have been shown to have WOMAC Pain scores that are, on average, more than double that of persons with pain localized over the patella (3). This association, however, relied on bivariate statistical testing (3) or small samples (1). Given the ubiquitous use of pain pattern assessment in clinical practice, further determination of associations between pain location and knee OA K&L categories and associations between pain location and self-reported pain with activity or functional status on a large sample of symptomatic knees is warranted.

Our study had two purposes. First, we determined the patterns of patient-reported pain locations for persons with the full range of K&L grades from 0 to 4 and for knees with isolated medial and isolated lateral compartment tibiofemoral radiographic OA grades from 0 to 3 (4). Second, we examined associations between knee pain patterns and severity of self-reported pain with activity and self-reported functional status after adjustment for potential confounding.

Methods

Participants were 2,696 persons from the parent Osteoarthritis Initiative study of 4,796 persons with or at risk of knee osteoarthritis (5). We selected only those persons who attended the in-person data collection session during the year 2 visit of OAI and who reported having had knee pain or aching in one or both knees in the previous 30 days. The year 2 visit was used because this visit was the only session in which pain pattern was determined using knee pain maps(6). We used the OAI reported knee pain map data for the painful knee for subjects with unilateral pain and randomly selected only one knee for subjects with bilateral knee pain to maintain data independence. We had data from 1,395 left knees and 1,301 right knees in the study. We decided to include knees with no radiographic knee OA because these patients also seek clinical care and in addition, we wanted to report on the entire disease spectrum from no OA disease to end-stage disease as measured with the K&L and Osteoarthritis Research Society International (OARSI) systems.

All persons underwent yearly flexed knee standing radiographs. K&L grades of 0 (no radiographic OA) to 4 (large osteophytes, marked narrowing of joint space, severe sclerosis and definite deformity of bone ends) for tibiofemoral joints (7) and OARSI grades of O (no OA in both compartments) to 3 (67% to 100% joint space narrowing in one compartment and 0 in the other compartment) for both medial and lateral tibiofemoral compartments (4) were provided by OAI investigators. An extensive adjudication process was used for K&L and OARSI grades for all knees over all time periods. Two central site readers and a third adjudicator, all either a rheumatologist or a musculoskeletal radiologist with extensive training and experience with K&L and OARSI grading read the radiographs. Test-retest reliability was substantial to almost perfect with weighted Kappa coefficients for both K&L grades ranging from 0.70 to 0.80 for 300 randomly selected knee films (8).

Assessments of Knee Pain Location using Pain Maps

Trained interviewers instructed subjects to either point with one or two fingers to the localized area of their knee pain or, if the pain was more diffuse, to put their hand over the area of the pain. The examination was conducted while the person was sitting. The interviewers recorded data on a knee pain map, an anatomical diagram of the knee. Pain location was coded as either localized, regional or global. Localized pain was coded as medial or lateral joint line, patellar or superior medial, superior lateral, inferior medial or inferior lateral. Regional pain was coded as either medial, lateral, patellar or posterior knee. If a subject reported more than 4 localized pain areas or more than two regional areas, the data were coded as global knee pain. Subjects were asked to identify all knee pain locations over the past 30 days. Subjects could have greater than one pain location in a knee. Reliability for this approach ranges from Kappa = 0.7 to 1.0.(6)

The Knee Injury and Osteoarthritis Outcome Survey (KOOS) Pain and WOMAC Function scores were used to quantify the extent of activity limiting knee pain and functional status, respectively. Both scales have been extensively validated (912). The WOMAC Function Scale ranges from 0 to 68 with higher scores equating to worse function and asks patients to rate the extent of difficulty associated with 17 daily activities. The WOMAC Function scale is identical to the KOOS Function scale but is scored differently. The KOOS Pain scale ranges from 0 to 100 with higher scores equating to less pain. The KOOS Pain Scale was chosen over the WOMAC Pain Scale because KOOS Pain has 4 additional items which allows for a more comprehensive assessment of the pain with activity construct. Both scales were obtained for each knee. To describe the sample and to adjust for potential confounding, we also report age, sex, BMI, gender, race and K&L grade.

Statistical analyses

Part 1

We report pain locations using radar graphs to illustrate the distributions for K&L and OARSI scores for each of the localized, regional and global pain locations. To reduce the total number of lines on the radar graphs to a manageable number, we collapsed some of the localized pain locations. All reports of localized medial knee pain (i.e., joint line, superior medial and inferior medial) were reported in the radar graphs as “localized medial knee pain.” The same approach was used to classify localized lateral knee pain. These two localized pain categories combined with localized patellar pain represented all the localized pain reports on the radar graphs. These were combined with the four regional pain categories and, along with global pain represents a comprehensive summary of the localized, regional and global pain locations.

The graphical approach allows for rapid visual assessment of the extent of overlap in pain location prevalence among pain patterns across different OA severities and locations. Given that pain location data are used by clinicians at the individual patient level, we believe this approach affords a more clinically useful interpretation of the data as compared to statistical comparisons across groups. Each spoke on the radar graph represents a pain location and the length of each spoke represents the prevalence of a pain location in the studied sample. In our study we labeled the vertical spoke with a prevalence ranging from 0% to 40%. The overall pattern of all spokes in a radar graph allows the reader to quickly assess pain patterns for a large group of patients and, in our case, allows for a rapid comparison of pain patterns and specifically the extent of overlap across different levels of OA disease locations and severities. We chose not to conduct formal statistical testing of pain categories. Statistical tests would likely show statistical differences even for very small differences in prevalence among disease severity groups because we had very large samples for most disease categories.

Part 2

We used ANCOVA models to analyze associations between two self-report scales (KOOS Pain and WOMAC Function) and knee pain location. We were interested in the association between the self-reported scales and pain location after adjusting for variables commonly associated with pain intensity and knee OA(1316) and these were BMI, age, gender, race (African American and non-African American) and K&L score. For this analysis we collapsed pain location categories into localized, regional and global subgroups. We reasoned that localized, regional and global pain locations capture sequentially larger areas of pain and larger areas of pain may associate with self-reported function and pain differently than smaller areas of pain. This premise has been supported in prior work(1;3).

Race was dichotomized because of very small numbers of persons self-categorized as other non-white and Asian. We used a backwards stepwise model selection procedure to build our models. The starting model included the independent variables: BMI, age, gender, race, K&L score, pain location and two-way interactions with pain location and the other predictors. To build the final model, variables were sequentially removed from the model until all independent variables were significant below a cutoff value of p=0.05. Further, the KOOS and WOMAC scales did not follow a Gaussian distribution so a transformation was required for statistical modeling. We used a Box-Cox transformation with λ=2 for the KOOS Pain scale and a square root transformation for the WOMAC Function scale. The estimated group differences were then back-transformed to be reported in the original KOOS pain and WOMAC scale points. The KOOS Pain scale was back transformed by inverting the Box-Cox transformation formula

originalscale=(2×gm×t)+1

where gm is the geometric mean and t is the transformed value. The WOMAC function scale was back-transformed by squaring the transformed value. Note that the use of these transformations does not result in a change of direction for differences. A Bonferroni correction was used to correct for multiple comparisons. All analyses were done using JMP Pro 11.1.1. SAS Institute Inc., Cary, NC.

Results

Part 1

Our sample comprised 2,696 persons, 57.3% were female, 16.9% were African American and the mean age was 62.7 (S.D. 9.1) years (see Table 1). The radar graphs for the various K&L and OARSI grades are illustrated in the Figure. The radar graphs summarize the prevalence of each pain pattern (localized medial, localized lateral, localized patellar, regional lateral, regional medial, regional patellar, regional pain in the back of the knee, and global knee pain). For each radar graph the percentage of subjects with each K&L (or OARSI) grade who reported pain in each pain pattern is presented. For example, part A of the figure illustrates pain patterns across the entire Kellgren and Lawrence disease spectrum. While medial knee pain is most prevalent in the sample (i.e., the vertical spokes show the highest prevalence) pain in other regions of the knee are only slightly less prevalent. In addition, pain patterns vary only slightly for K&L grades from 0 to 4. These graphical data suggest that there is substantial variation in pain locations among individuals with either the same or different K&L grades.

Table 1.

Characteristics of the study sample (n = 2,696)

Variable Average (sd) or Count (Percent)
Sex (female) 1,544 (57.3%)
Age (years) 62.7 (9.1)
Body Mass Index (kg/meters2) 29.0 (5.0)
Race
 African American 456 (16.9%)
 Causasian or other 2,236 (83.1%)
Kellgren and Lawrence Score
 0 771 (29.6%)
 1 411 (15.8%)
 2 702 (27.0%)
 3 500 (19.2%)
 4 218 (8.4%)
Osteoarthritis Research Society International Joint Space Narrowing Scores (medial, lateral)
 0 1,409 (56.9%), 1,554 (83.6%)
 1 600 (24.2%), 117 (6.3%)
 2 329 (13.3%), 114 (6.1%)
 3 138 (5.6%), 73 (3.9%)
KOOS Pain score* Median=83.3 (IQR = 22.2)
WOMAC Function score+ Median=6.4 (IQR = 15.9)
*

KOOS = Knee injury and Osteoarthritis Outcome Score

+

WOMAC = Western Ontario and McMaster Universities Osteoarthritis Index

Figure.

Figure

The figure illustrates radar graphs for K&L and OARSI grades for the complete sample. Panel A shows the distribution of K&L grades from 0 to 4, panel B shows OARSI grades from 0 to 3 for isolated medial joint space narrowing and panel B shows OARSI grades from 0 to 3 for isolated lateral joint space narrowing for all localized, regional and global pain patterns. Abbreviations are as follows: Local Med = localized medial pain, Local Lat = localized lateral pain, Local Pat = localized patellar pain, Reg Lat = regional lateral pain, Reg Med = regional medial pain, Reg Pat = regional patellar pain, Reg Back = regional pain in the back of the knee. To determine the prevalence, identify the grade of interest (e.g. Kellgren and Lawrence (K&L) grade of 4) and then identify the point on the graph where the K&L Grade of 4 intersects the radar graph. In the case of localized medial pain in panel A for a K&L grade of 4, approximately 35.3% of persons had localized medial knee pain.

Part 2

The model used for the WOMAC Function scale included the following predictors; BMI, age, gender, race, K&L score, pain location and a pain location by race interaction. African American subjects reported significantly higher (p< 0.05) WOMAC Function scores across pain location categories as compared to non-African American subjects. For example, WOMAC Function scores among African Americans in the global pain group had a substantially and clinically important worse mean score as compared to the localized pain group of approximately 7 points. For the non-African American subjects, the global pain group had a WOMAC Function score that was slightly less than 2 points higher than the localized pain group. The median WOMAC Function score was 20.2 (IQR=23.4) for the African American subjects with global pain while the median WOMAC Function score for the non-African American subjects with global pain was 7 (IQR=16). Regional pain and localized combined with regional pain also was associated with worse WOMAC Function in African American (by 3 to 8 WOMAC Function points) relative to pain that was localized. Differences between regional and localized pain were not found for the non-African American subjects.

The model used for inferences using the KOOS Pain scale included the following predictors; BMI, age, gender, race, K&L score and pain location. There was no pain location by race interaction found for KOOS Pain scores. We found, for example, that patients with global pain report significantly lower (worse) scores than patients with localized pain (p < 0.001)or regional pain (p = 0.002). Score differences were on the order of 3 to 4 KOOS Pain points higher (indicating worse pain) for regional and global pain relative to localized pain. Patients with regional only pain also had worse KOOS Pain scores than persons with only localized pain (p=0.035) resulting in worse pain by approximately 1.5 points for regional relative to localized pain. See Table 2 for results of both models.

Table 2.

Analysis of covariance models# for associations between pain location and KOOS Pain and WOMAC Physical Function

Measure Pain group Comparator Pain group Transformed Difference Std Err 95% CI p-Value Back-Transformed Difference^
KOOS Pain
 localized global 3.87 0.78 1.85, 5.90 <0.001* 3.90
 localized localized and regional 3.74 1.95 −1.28, 8.75 0.056* 3.75
 regional only global 2.55 0.82 0.43, 4.67 0.002* 2.59
 regional only localized and regional 2.41 1.97 −2.65, 7.47 0.22* 2.44
 localized regional only 1.33 0.63 −0.29, 2.94 0.035* 1.31
 localized and regional global 0.14 2.03 −5.07, 5.35 0.94* 0.15
WOMAC Function+
African Americans
  localized global 0.88 0.21 0.46, 1.30 <0.001¥ 6.52
  localized localized and regional 1.06 0.54 0.01, 2.12 0.05¥ 8.08
  regional only global 0.39 0.21 −0.03, 0.81 0.07¥ 3.06
  regional only localized and regional 0.57 0.54 −0.49, 1.63 0.29¥ 4.62
  pain localized regional only 0.49 0.18 0.13, 0.85 0.007¥ 3.46
  localized and regional global 0.18 0.55 −0.90, 1.26 0.74¥ 1.56
Others
  localized global 0.34 0.10 0.14, 0.55 0.001¥ 1.81
  localized localized and regional 0.16 0.25 −0.33, 0.66 0.52¥ 0.84
  regional only global 0.27 0.11 0.05, 0.48 0.01¥ 1.44
  regional only localized and regional 0.09 0.26 −0.41, 0.60 0.73¥ 0.47
  localized regional only 0.07 0.08 −0.08, 0.23 0.36¥ 0.37
  localized and regional global 0.18 0.27 −0.34, 0.70 0.50¥ 0.97
*

Student’s T p-values compared to Bonferroni cut-off value of 0.008

¥

Student’s T p-values compared to Bonferroni cut-off value of 0.004

#

Models are adjusted for Kellgren and Lawrence score, age, gender, body mass index and race.

+

The comparisons are reported separately for African American subjects and for all other subjects.

^

The back-transformed difference represents the difference among pain groups in the units of interest. These differences are interpreted such that the value indicates the magnitude of difference between the two pain locations. For example, for KOOS Pain, the difference between the global and the localized group is 3.9 KOOS Pain points. This indicates that after adjustment for other covariates in the model, the global pain group had a KOOS pain score that was 3.9 points lower (indicating worse pain) as compared to the local pain group.

Minimal clinically important difference (MCID) estimates are frequently used to interpret group differences in clinical trials and provide a context for interpretation of the differences between groups in our study(17). MCIDs for the osteoarthritis outcome measures have consistently been estimated to be approximately 25% relative to baseline scores(1820). The better the baseline score (i.e. the larger the KOOS or the smaller the WOMAC score), the smaller the change necessary to conclude that clinically important differences exist. Our baseline scores indicated mostly mild or moderate pain and functional loss. Changes required to infer a clinically important difference between groups were generally small and on the order of 2 or 3 scale points for KOOS and WOMAC scales. Applying this threshold to our data, allows for an interpretation of the potential meaningfulness of the differences we found. For example, the global pain pattern group had clinically important and worse KOOS pain scores relative to the localized and regional groups and WOMAC function differences particularly for the African American subjects are likely to be clinically important.

Discussion

We found that pain location patterns for K&L and OARSI scores showed substantial overlap across tibiofemoral OA locations and severity levels and while persons with isolated medial joint space narrowing demonstrated a tendency toward more medial knee pain (and vice versa for lateral joint space narrowing) there was still a substantial percentage who reported pain in a variety of knee locations, even when OA was isolated to either the medial or lateral tibiofemoral compartment. These descriptive data suggest that knee pain location does not inform decisions regarding likely location(s) of tibiofemoral OA or severity of radiographic tibiofemoral OA when considering an individual patient. The variability and degree of overlap among disease severity categories is simply too great, in our opinion, to provide initial diagnostic information.

Independent associations between pain location and self-reported KOOS pain suggest that global pain is associated with more severe pain with activity than localized or regional pain. This difference is on the order of 2 to 4 KOOS Pain points. For WOMAC Function scores, African American subjects demonstrated substantial differences of approximately 7 points when pain was reported as global versus local. Among all other subjects of which 97% were Caucasian, differences also were found among those with global versus those with localized pain but these differences were small, approximately 2 WOMAC Function points. No other statistically significant differences were found among the other pain locations.

When applying the MCID to interpretation of the differences we found, some clinically important differences are likely. For example, KOOS pain scores for persons with global knee pain relative to those with either localized or regional pain are likely to be important. Patients with global knee pain consistently had worse KOOS pain scores. For WOMAC Function, application of MCID estimates of 2 or 3 WOMAC Function points for persons with mild or moderate functional loss indicate that all statistically significant differences we found for African American subjects are likely to be clinically important. Regional and global pain patterns are associated with clinically important reduced function relative to localized pain groups. However, for non-African American subjects, the only statistically significant and clinically important difference was for the global relative to the localized pain group.

Reasons for the race by pain location interaction for WOMAC Function but not for KOOS Pain was a surprising finding. African Americans have been found to have significantly worse pain and function scores after controlling for radiographic severity and age and these higher scores have been shown to be associated with higher BMI and worse mental health(21). WOMAC Function scores quantify the difficulty during functional tasks while KOOS Pain scores quantify the extent of pain during functional tasks. These measures are strongly correlated for persons with OA(22) but in our study the race by pain location interaction was only found for WOMAC Function. We suspect one of two reasons for this finding. Pain location may simply have a greater impact on functional status difficulty than pain during function for African Americans as compared to non-African American subjects. The other possibility is that WOMAC Function consists of 17 items while KOOS Pain contains only 9 items and it may be that WOMAC Function is a more psychometrically sound measure of the construct of interest particularly when considering pain location. Our study supports the need for more research in this area.

In an a posteriori analysis we examined the diagnostic validity for pain location assessments by determining the sensitivity, specificity and likelihood ratios when considering knees with isolated medial joint space narrowing and no lateral joint space narrowing (n=1066) and knees with isolated lateral joint space narrowing and no medial joint space narrowing (n=273). We used the OARSI joint space narrowing measurements in the OAI to identify persons with isolated medial or isolated lateral joint space narrowing. We considered this analysis a best case scenario diagnostic test approach because the knees of interest only had unicompartmental disease. We tested whether pain location (either medial or lateral) could “diagnose” either isolated medial or isolated lateral knee OA with joint space narrowing. If a person reported any medial knee pain and had isolated medial knee joint disease this was considered a diagnostically positive test and vice versa for the lateral compartment. Table 3 summarizes the findings. Briefly, the sensitivity, specificity were all 0.7 or less and all likelihood ratios were between 0.5 and 2.0 which indicate that even considering the best case scenario of isolated medial or lateral knee compartment disease and no other OA combinations, pain location is not diagnostically accurate enough for routine clinical use.

Table 3.

Diagnostic test validity indexes for identifying persons with either isolated medial compartment knee osteoarthritis (n=1066) or isolated lateral compartment knee osteoarthritis (n=273)

Knee Pain Location Test Result Knee OA Status Sensitivity (95% CI) Specificity (95% CI) + Likelihood Ratio (95% CI) − Likelihood Ratio (95% CI)
Any medial knee pain Isolated Medial Compartment Disease 0.51 (0.48–0.54) 0.63 (0.57–0.69) 1.35 (1.15–1.60) 0.79 (0.71–0.88)
Any lateral knee pain Isolated Lateral Compartment Disease 0.48 (0.42–0.54) 0.70 (0.67–0.73) 1.60 (1.37–1.87) 0.74 (0.66–0.84)

Our findings are consistent with others in that global pain has been reported to be associated with worse self-reported pain and function as compared to other pain patterns [1, 3]. However, our work builds on this past evidence by examining a very large sample, accounting for OA severity and location and adjusting for potential confounders. Our study is limited because we did not have patellofemoral OA data and our analysis was restricted to cross sectional associations.

In conclusion, our radar graph data suggest that pain pattern and extent or location of tibiofemoral radiographic OA are only weakly related if at all and that the extent of pain overlap among OA disease severity subgroups is likely too great for individual patient application. Knee pain reported to be global has a clinically important association with self-reported KOOS pain scores. Global pain and regional pain patterns also have a strong association with worse functional status relative to localized pain reports and this is particularly true for African Americans relative to non-African Americans. We encourage clinicians to use reports of pain location and particularly reports of global and regional pain as these reports are independently associated with activity related pain and function. Pain location does not appear to be helpful for inferring radiographic OA location or severity.

Acknowledgments

Funding Statement: The OAI is a public-private partnership comprised of five contracts (N01-AR-2-2258; N01-AR-2-2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Merck Research Laboratories; Novartis Pharmaceuticals Corporation, GlaxoSmithKline; and Pfizer, Inc. Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. This manuscript was prepared using an OAI public use data set and does not necessarily reflect the opinions or views of the OAI investigators, the NIH, or the private funding partners.

Financial Support Statement: The authors disclose no financial support or other benefits from commercial sources for the work reported on in the manuscript, or any other financial interests which could create a potential conflict of interest or the appearance of a conflict of interest with regard to the work.

Footnotes

Conflict of Interest Statement: The authors declare no conflicts of interest.

Contributor Information

Daniel L. Riddle, Departments of Physical Therapy and Orthopaedic Surgery, Virginia Commonwealth University, Richmond, Virginia, USA.

Mateusz Makowski, Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia, USA.

Reference List

  • 1.Creamer P, Lethbridge-Cejku M, Hochberg MC. Where does it hurt? Pain localization in osteoarthritis of the knee. Osteoarthritis Cartilage. 1998;6:318–23. doi: 10.1053/joca.1998.0130. [DOI] [PubMed] [Google Scholar]
  • 2.Thompson LR, Boudreau R, Newman AB, Hannon MJ, Chu CR, Nevitt MC, et al. The association of osteoarthritis risk factors with localized, regional and diffuse knee pain. Osteoarthritis Cartilage. 2010;18:1244–9. doi: 10.1016/j.joca.2010.05.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Wood LR, Peat G, Thomas E, Duncan R. Knee osteoarthritis in community-dwelling older adults: are there characteristic patterns of pain location? Osteoarthritis Cartilage. 2007;15:615–23. doi: 10.1016/j.joca.2006.12.001. [DOI] [PubMed] [Google Scholar]
  • 4.Altman RD, Gold GE. Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthritis Cartilage. 2007;15 (Suppl A):A1–56. doi: 10.1016/j.joca.2006.11.009. [DOI] [PubMed] [Google Scholar]
  • 5.Lester G. Clinical research in OA--the NIH Osteoarthritis Initiative. J Musculoskelet Neuronal Interact. 2008;8:313–4. [PubMed] [Google Scholar]
  • 6.Thompson LR, Boudreau R, Hannon MJ, Newman AB, Chu CR, Jansen M, et al. The knee pain map: reliability of a method to identify knee pain location and pattern. Arthritis Rheum. 2009;61:725–31. doi: 10.1002/art.24543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494–502. doi: 10.1136/ard.16.4.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74. [PubMed] [Google Scholar]
  • 9.Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833–40. [PubMed] [Google Scholar]
  • 10.Bellamy N. The WOMAC Knee and Hip Osteoarthritis Indices: development, validation, globalization and influence on the development of the AUSCAN Hand Osteoarthritis Indices. Clin Exp Rheumatol. 2005;23:S148–S153. [PubMed] [Google Scholar]
  • 11.Roos EM, Lohmander LS. The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health Qual Life Outcomes. 2003;1:64. doi: 10.1186/1477-7525-1-64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Roos EM, Bremander AB, Englund M, Lohmander LS. Change in self-reported outcomes and objective physical function over 7 years in middle-aged subjects with or at high risk of knee osteoarthritis. Ann Rheum Dis. 2008;67:505–10. doi: 10.1136/ard.2007.074088. [DOI] [PubMed] [Google Scholar]
  • 13.Cruz-Almeida Y, Sibille KT, Goodin BR, Petrov ME, Bartley EJ, Riley JL, III, et al. Racial and ethnic differences in older adults with knee osteoarthritis. Arthritis Rheumatol. 2014;66:1800–10. doi: 10.1002/art.38620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Jordan JM, Helmick CG, Renner JB, Luta G, Dragomir AD, Woodard J, et al. Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project. J Rheumatol. 2007;34:172–80. [PubMed] [Google Scholar]
  • 15.Neogi T, Zhang Y. Epidemiology of osteoarthritis. Rheum Dis Clin North Am. 2013;39:1–19. doi: 10.1016/j.rdc.2012.10.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Rheum Dis Clin North Am. 2008;34:515–29. doi: 10.1016/j.rdc.2008.05.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10:407–15. doi: 10.1016/0197-2456(89)90005-6. [DOI] [PubMed] [Google Scholar]
  • 18.Angst F, Aeschlimann A, Steiner W, Stucki G. Responsiveness of the WOMAC osteoarthritis index as compared with the SF-36 in patients with osteoarthritis of the legs undergoing a comprehensive rehabilitation intervention. Ann Rheum Dis. 2001;60:834–40. [PMC free article] [PubMed] [Google Scholar]
  • 19.Angst F, Aeschlimann A, Stucki G. Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum. 2001;45:384–91. doi: 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  • 20.Angst F, Aeschlimann A, Michel BA, Stucki G. Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities. J Rheumatol. 2002;29:131–8. [PubMed] [Google Scholar]
  • 21.Allen KD, Helmick CG, Schwartz TA, DeVellis RF, Renner JB, Jordan JM. Racial differences in self-reported pain and function among individuals with radiographic hip and knee osteoarthritis: the Johnston County Osteoarthritis Project. Osteoarthritis Cartilage. 2009;17:1132–6. doi: 10.1016/j.joca.2009.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Stratford PW, Kennedy DM. Does parallel item content on WOMAC’s pain and function subscales limit its ability to detect change in functional status? BMC Musculoskelet Disord. 2004;5:17. doi: 10.1186/1471-2474-5-17. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES